Robeco Institutional Asset Management B.V. Trims Stake in LHC Group, Inc. (NASDAQ:LHCG)

Robeco Institutional Asset Management B.V. lowered its position in LHC Group, Inc. (NASDAQ:LHCG) by 50.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,357 shares of the health services provider’s stock after selling 24,357 shares during the period. Robeco Institutional Asset Management B.V. owned 0.08% of LHC Group worth $3,355,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Advisory Services Network LLC boosted its position in shares of LHC Group by 44.0% in the 4th quarter. Advisory Services Network LLC now owns 242 shares of the health services provider’s stock worth $33,000 after purchasing an additional 74 shares in the last quarter. Synovus Financial Corp boosted its holdings in LHC Group by 130.8% in the third quarter. Synovus Financial Corp now owns 300 shares of the health services provider’s stock worth $34,000 after acquiring an additional 170 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in LHC Group by 50.6% in the third quarter. Tower Research Capital LLC TRC now owns 491 shares of the health services provider’s stock worth $56,000 after acquiring an additional 165 shares in the last quarter. Quest Capital Management Inc. ADV purchased a new stake in shares of LHC Group in the third quarter worth $147,000. Finally, Virtu Financial LLC purchased a new stake in shares of LHC Group in the fourth quarter worth $207,000. Institutional investors own 92.67% of the company’s stock.

LHCG has been the subject of several recent analyst reports. SunTrust Banks lifted their price target on LHC Group from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. BidaskClub raised shares of LHC Group from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 23rd. William Blair restated an “outperform” rating on shares of LHC Group in a research note on Thursday, November 7th. Finally, Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $145.00 target price for the company in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $134.82.

Shares of LHCG stock traded down $1.05 during mid-day trading on Thursday, hitting $154.28. The company’s stock had a trading volume of 11,591 shares, compared to its average volume of 144,102. The stock has a market cap of $5.01 billion, a price-to-earnings ratio of 51.18, a PEG ratio of 2.41 and a beta of 0.88. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.53 and a current ratio of 1.53. LHC Group, Inc. has a 52-week low of $98.41 and a 52-week high of $159.48. The business has a 50-day moving average price of $147.67 and a 200 day moving average price of $129.01.

LHC Group Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

See Also: Pattern Day Trader – What is the PDT Rule?

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit